Archive for the ‘Treatment’ Category

Repair Neuropathy: Dr. Marty Ross

https://www.treatlyme.net/guide/neuropathy-repair-heal-that-tingling-numbness-pain  Video Here

Neuropathy in Tick-borne Infections and Mold Toxicity

In chronic Lyme disease it is common to have nerve injury in locations outside of the brain and spinal cord – also called peripheral neuropathy. Common symptoms of peripheral neuropathy include:

  • numbness,
  • burning sensations,
  • and/or sharp, stabbing or electric feelings.

In this article Marty Ross MD reviews:

  • laboratory evaluation of neuropathy in chronic Lyme disease and
  • a functional medicine approach to remove nerve insults and to repair nerve injury.

Neuropathy Laboratory Evaluation

A basic laboratory evaluation of neuropathy may include:

  • Vitamin B6 (too much Vitamin B6 causes neuropathy)
  • Vitamin B12 (low Vitamin B12 causes neuropathy)
  • Vt D3 (levels around 40 ng/ml to 80ng/ml support healthy nerve function)
  • CBC
  • CMP (evaluation of kidney and liver function)
  • TSH, Free T3, and Free T4 (evaluate for low or high thyroid function)
  • TTG-IgA & EMA (for possible celiac disease)
  • heavy metal urine testing (see the end of the article for when to do this)

Functional Medicine Neuropathy Repair

Steps to repair nerve injury include:

removing the nerve insults

  • correcting abnormal labs including thyroid, Vitamin D, Vitamin B6, and Vitamin B12
  • stopping RX meds that may cause neuropathy
  • treating infections
  • correcting mold toxicity

repairing the nerve damage

  • repairing nerve cell and mitochondria power plant membranes,
  • increasing the master cell repair antioxidant glutathione,
  • increasing the nutrient Coenzyme Q10 (CoQ10)
  • taking acetyl-l-carnitine if you do not eat red meat,
  • decreasing inflammation, and
  • using the peptide BPC-157.

Remove Nerve Insults

Treat Infections

The three major infections seen in Lyme disease (Borrelia (Lyme), Bartonella, and Babesia can lead to nerve injury. Of these, Borellia and Bartonella have a greater chance of causing this condition. For information on treating the infections see: A Lyme Disease Antibiotic Guide, Kills Bartonella: A Brief Guide, and Kills Babesia: A Brief Guide.

Stop RX Meds that Cause Neuropathy

There are a number of medications that can cause neuropathy. You should review your list of medications with your physician or health care provider. There are three classes of anti-microbials used in Lyme treatments that can lead to neuropathy.

  • azoles including fluconazole (Diflucan), metronidazole, tinidazole, and itraconazole
  • Plaquenil (hydroxychloroquine)
  • disulfiram
Correct Mold Toxicity

Elevated mold toxins may injur nerve function and damage nerve cell mitochondria. See Mold and Lyme Toxin Illness for more information about how to diagnose and fix this problem. (See link for article and video)

Category:

Lyme, Mold, Supplements, Treatment

The Importance of Looking at Parasites, Viruses, Yeast and Fungal Infections

https://www.lymedisease.org/parasites-viruses-yeast-fungal-infections/

The Importance of Looking at Parasites, Viruses, Yeast and Fungal Infections

By Dr. Richard Horowitz
 
In his book Why Can’t I Get Better: Solving the Mystery of Lyme and Chronic Disease, Dr. Richard Horowitz proposes what he calls the MSIDS model. It stands for Multiple Systemic Infections Disease Syndrome and takes a broad look at how many different factors can contribute to persistent illness. In the following excerpt, he discusses several of the factors that can complicate diagnosis and treatment of Lyme disease.

Parasitic Infections

Intestinal parasites like giardiaIntestinal parasites like giardia, amoeba, pinworm, hookworm, schistosomiasis, and strongyloides are part of the MSIDS map. These infections are found on both serum antibody testing and stool cultures (i.e., local labs, Genova stool CDSA). Although we generally think of parasitic worms as only inhabiting the GI tract, Dr. Alan MacDonald recently found nematode filarial worms in the cerebrospinal fluid of patients with multiple sclerosis and Alzheimer’s disease at autopsy. Dr. Eva Sapi has found filarial worms in Ixodes scapularis ticks, and Zhang and colleagues found them in lone star ticks, so it is possible that filarial worms are being regurgitated from the gut of the tick into humans after a tick bite. Dr. Steven Fry has found parasites in the bloodstream living in biofilms, called Protomyxoa rheumatica (FL-1953), which are composed of up to eight different genetic types of parasites. Babesia suppresses our ability to clear other parasites, so are multiple parasites partially responsible for chronic illness in Lyme-MSIDS?

Parasites apart from Babesia can play an important role in keeping chronic Lyme patients sick, and antiparasitic regimens are often important.

Regimens including Biltricide, ivermectin, pyrantel pamoate (Pin-X), paromomycin, Alinia, and Albenza have been effective in certain patients with not only persistent GI symptoms but also fatigue, headaches, and myalgias resistant to classical tick-borne therapy. Some Morgellons patients report noticing help using antiparasitic drugs in combination with regimens against Lyme and tick-borne co-infections (like Bartonella), and some neuropsychiatric Lyme patients have seen improvement in cognition and behavior with antiparasitic drugs. Make sure you do a comprehensive parasite evaluation if you or your patient is not getting better.  (See link for article)

__________________

For more:

Category:

Parasites, Treatment, Viruses

Study: Ivermectin Reduces ICU Admission by 83%

**UPDATE**

The U.S. government ‘cartel’ paid large pharmacy chains like Walgreens and CVS billions of dollars to promote COVID-19 vaccines and not fill prescriptions for ivermectin.

https://brieflands.com/articles/jjhs-146703

Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial

 Authors: Mehran VarnaseriORCID1 , Fatemeh Amini2 , Ramin Jamshididan1 , Mehrdad Dargahi3 , Nematollah GheibiORCID3 , Sara AbolghasemiORCID3 , Mohammadreza Dayer4 , Negar Varnasseri3 , Khojasteh Hoseinynejad5 , * , Sahar Kheradhoosh3 , Pedram Nazari6 , ** , Ebrahim Babadi7 , Seyedeh Maryam Mousavinezhad6 , Pouya EbrahimiORCID8
Corresponding Authors:

Jundishapur Journal of Health Sciences: Vol.16, issue 2; e146703
Published Online: April 30, 2024
Article Type: Research Article
 Received: March 10, 2024
 Revised: April 8, 2024
 Accepted: April 9, 2024
 DOI: https://doi.org/10.5812/jjhs-146703

Abstract

Background:

Addressing the Coronavirus disease 2019 (COVID-19) pandemic remains a significant challenge for healthcare systems globally. Despite the absence of a proven cure, ivermectin has been proposed as a potentially effective agent against it.

Objectives:

This study aimed to evaluate the therapeutic effects of ivermectin compared to a placebo group in non-critically ill confirmed COVID-19 patients.

Methods:

A double-blind, randomized clinical trial was conducted on 110 patients with moderate-to-severe (non-critical) confirmed COVID-19 infection. The patients were equally divided into two groups, with one group receiving ivermectin tablets (14 mg every 12 hours for three days) and the other group receiving a placebo. The efficacy and safety of ivermectin were assessed in both groups.

Results:

A total of 110 patients, including 62 (56.4%) men and 48 (43.6%) women, with an average age of 53.36 ± 15.10 years, were enrolled in our double-blind, randomized clinical trial. The baseline characteristics of the two groups were similar. The findings demonstrated that ivermectin significantly reduced the need for Intensive Care Unit admission (32.7% vs. 5.5%; P < 0.001), hospitalization duration (six vs. four days; P < 0.001), and median time to symptom resolution period (P < 0.05) in COVID-19 patients compared to the placebo group, without any serious side effects (P > 0.05).

Conclusions:

Ivermectin appears to be a potentially effective and safe medication for COVID-19 patients with moderate disease.

_________________
**Comment**
It’s important to note that the study only used ivermectin.  When you look at successful protocols, they include many other things to help the immune system.
For more:

Category:

Treatment, Viruses

Case Report: Lyme Neuroborreliosis With Encephalitis

https://danielcameronmd.com/case-report-lyme-neuroborreliosis-with-encephalitis/

CASE REPORT: LYME NEUROBORRELIOSIS WITH ENCEPHALITIS

lyme-encephalitis

Investigators describe what they believe is the first case of confirmed Lyme neuroborreliosis encephalitis with significant parenchymal MRI changes in a broadly immunosuppressed patient.

By 

A 74-year-old woman had been hospitalized four times over a period of three months. During these admissions, she was treated with antibiotics for a urinary tract infection, states Rosendahl and colleagues in their article “Lyme neuroborreliosis with encephalitis: A rare case.”¹

On her last admission, the woman exhibited confusion, paranoid delusions, a weight loss of 33 lbs., back pains, history of fever and vomiting suspect of cancer and infection of unknown origin, leading doctors to suspect she suffered from a central nervous system (CNS) infection.

“We present a case of Lyme neuroborreliosis with encephalitis with significant parenchymal inflammation on magnetic resonance imaging (MRI) in an immunosuppressed patient.”

A lumbar puncture was performed and she began empirical treatment for bacterial meningitis and viral encephalitis, which included benzylpenicilline, ceftriaxone, aciclovir and dexamethasone.

The woman reportedly had no history of a tick bite or an erythema migrans (EM) rash or painful meningoradiculitis. However, approximately 3 months earlier she was treated for a universal skin rash.

“An MRI showed hyperintensities in basal ganglia, thalami, medial temporal lobes and mesencephalon and hereby confirmed the diagnosis of [Lyme neuroborreliosis] encephalitis,” according to the authors.

The woman was treated successfully with intravenous ceftriaxone and oral doxycycline for Lyme neuroborreliosis.

“Follow-up brain MRI showed complete remission of previous hyperintensities in basal ganglia and thalamus,” the authors state. “At 6 months follow-up, the patient had improved but still reported some memory problems.”

References:
  1. Rosendahl SB, Ravn P, Lebech AM, Midtgaard Stenør CP. Lyme neuroborreliosis with encephalitis: A rare case. IDCases. 2023 Feb 3;31:e01704. doi: 10.1016/j.idcr.2023.e01704. PMID: 36845907; PMCID: PMC9947094.

_______________

**Comment**

Per usual, this patient should be followed for years, but won’t be because of the mythology that Lyme is a easy to treat pathogen.

Although this is the first reported case with such findings, I assure you – there are many others that fall through the cracks.

For more:

Category:

Lyme, research, Treatment

‘The Power of Natural Immunity’: COVID Challenge Trials Struggle to Infect Participants, Even at High Doses

https://childrenshealthdefense.org/defender/natural-immunity-uk-human-covid-challenge-trials/

‘The Power of Natural Immunity’: COVID Challenge Trials Struggle to Infect Participants, Even at High Doses

U.K. scientists attempting to deliberately reinfect healthy people with COVID-19 for vaccine and treatment testing found that even doses 10,000 times higher than the original could not induce sustained infection in participants with natural immunity from prior infection, as reported in The Lancet Microbe.

covid vaccine and hand holding key that reads "immunity"

Scientists trying to reinfect people with the COVID-19 virus so they could test vaccines and treatments found high levels of immunity made it nearly impossible, according to results from the COVID-19 “Human Challenge” trials in the U.K

The results, published May 1 in The Lancet Microbe, “raise questions about the usefulness of COVID-19 challenge trials for testing vaccines, drugs and other therapeutics,” Nature reported.

“If you can’t get people infected, then you can’t test those things,” Tom Peacock, Ph.D., a virologist at Imperial College London, told Nature.

Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense told The Defender, “The results show the power of natural immunity as compared to the many breakthrough infections in ‘naive’ vaccinated individuals.”

“Any assertion that vaccination-based immunity is more powerful than natural immunity is complete lunacy — the acquired immune system is a beautiful thing and vaccination is a cheaper and much less effective substitute,” he said. (See link for article)

_____________

**Comment**

And that is just what the past four years have brought us: LUNACY.

SUMMARY:

  • The 1st study in 2021 exposed 36 adults to the original strain of COVID via nasal droplets. Of those, only 53% eventually tested PCR-positive but had very mild or no symptoms. There was no correlation between severity and viral load.
  • The 2nd study funded by the Wellcome Trust and the U.K.’s Department of Health and Social Care infected people with COVID who already had natural immunity – some of which were ‘vaccinated’.  Between 2021 and 2022 scientists inoculated 36 adults with different COVID doses and then quarantined them for 14 days and tested them during that time and throughout 12 months. When the 1st subjects did not get infected, they increased the dose until it reached 10,000 times the original dose. They were unable to induce sustained infection in any subjects.  Five later got mild infections during the Omicron period.
  • Another challenge trial is ongoing at Imperial College London but is also having trouble infecting participants, even though it’s with the Delta strain. The lead researcher received a $57 million grant from the European Union and the Bill & Melinda Gates Foundation-backed CEPI, the Coalition for Epidemic Preparedness Innovations, to use challenge trials to develop  inhaled and intranasal COVID-19 vaccines.

Saddest excerpt of all:

They are continuing to try to develop ways to actually infect trial subjects so they can develop vaccines. Those methods include giving people multiple doses of the vaccine or finding people who have low levels of immune protection.

So there you have it.

This reminds me of the failed experiment to infect volunteer inmates with the Spanish flu, also known as the Great Swine Flu – to develop a ‘magic bullet’ vaccine which also caused severe adverse reactions.  ZERO people got infected despite being injected with infected lung tissue from sick or deceased patients, having infected tissue dropped in their eyes, and sprayed in the nose and mouth with infectious aerosols. Others would see mucus taken from critically ill patients and put it into the noses and throats of prisoners. In other parts of the trials, experimenters would take the blood of the sick and inject it into the healthy, to see if it was spread through infectious microorganisms in the blood.  Nobody got sick and nobody died.

This should raise some questions.  What exactly were people dying from?

And this is the question that needs to be asked of COVID and every other ‘infectious’ disease that can’t be purposely used to infect others, and I’m not simply talking about a fraudulent positive PCR test that changes like the wind.  I’m talking about symptoms that make you sick.

People have certainly gotten severely ill, but with what, and why do anti-parasitic medications work on a supposed virus, which BTW, also work on cancer?  Hmmm…

Go here for more fundamental truths and busted persistent myths about cancer treatments.

For more:

  • https://madisonarealymesupportgroup.com/2020/07/10/coronavirus-why-everyone-was-wrong/  Excerpt:
    • Firstly, it was wrong to claim that this virus was novel.
    • Secondly, It was even more wrong to claim that the population would not already have some immunity against this virus.
    • Thirdly, it was the crowning of stupidity to claim that someone could have Covid-19 without any symptoms at all or even to pass the disease along without showing any symptoms whatsoever.  – Beda M Stadler

Category:

research, Transmission, Treatment, vaccines, Viruses